DNTH vs H · rev $6.2M vs rev $6.65B
Dianthus Therapeutics Inc. (DNTH) versus Hyatt Hotels Corporation (H) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Hyatt Hotels Corporation (H) is a lodging company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported H revenue for 2024-12-31 was $6.65B. Net income was $1.30B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. H currently screens at market cap $17.08B.
DNTH currently screens at market cap $4.40B. H currently screens at market cap $17.08B.
Not investment advice. Open the DNTH and H stock pages for the full models.
Not investment advice.